Spotlight on TAC Provinces
The Treatment Action Campaign (TAC) reports for Spotlight on some of its recent work in the seven provinces where TAC has branches and provincial structures.
The Treatment Action Campaign (TAC) reports for Spotlight on some of its recent work in the seven provinces where TAC has branches and provincial structures.
Cryptococcosis (“crypto”) is a common AIDS-defining fungal opportunistic infection worldwide. It has been neglected for many years. This is about to change.
Treatment Action Campaign (TAC) Chairperson Nkhensani Mavasa delivered the below speech at the opening of the TAC’s sixth National Congress on 23 August 2017. The speech has been lightly edited for publication.
Just as with HIV, every single one of us knows another person who is experiencing mental ill health. However, this may be hidden – due to stigma, shame, lack of understanding, and lack of adequate treatment, writes Professor Francois Venter.
We have prepared a special print edition of Spotlight to coincide with
the Treatment Action Campaign’s 6th National Congress taking place
from 23 to 25 August 2017. Amongst others it contains updates from all
seven TAC provinces and articles on treatment adherence and the future
of ART
At the end of this year, South Africa’s big plan to fight HIV and tuberculosis comes to an end. The National Strategic Plan for HIV, TB and STIs 2012-2016 will be replaced by the 2017-2021 NSP. It is vital that the new NSP avoids the mistakes of the past and fully incorporates new scientific evidence.
This open letter from Mark Heywood appeared on Spotlight’s website and in the Daily Maverick at the end of August. While we are three months further down the line, the issues highlighted by Mark are still relevant and important to take note of as the new plan for HIV and TB is crafted. We welcome responses to this, please write to the Editor and let’s talk!
South Africa’s HIV and TB plan for the next five years has been riddled with controversy. Here’s our assessment of the plan.
The South Gauteng High Court this week ruled in favour of the SA HIV Clinicians Society in its legal battle with a doctor who promoted a product marketed as Dr Hugh’s Dermo Blue Pre-sex Protection Gel, which claimed to prevent HIV infection.
By Marcus Low – Medical research findings are often sensationalised and overstated in the mainstream media. We debunk three cases of HIV-related misreporting that caught our eye in recent months.